Ribon Therapeutics Secures $65 Million Financing

15 Jul, 2021

Ribon Therapeutics Secures $65 Million Financing
Photo by Brian Kyed on Unsplash

– Ribon Therapeutics announced the closing of a $65m financing.
– The financing was led by Deerfield Management and U.S. Venture Partners, with support from new investors Avego BioScience Capital, GV (formerly Google Ventures), Monashee Investment Management and Peregrine Ventures, along with existing investors AbbVie Ventures, Bristol Myers Squibb, Euclidean Capital, Johnson & Johnson Innovation, Novartis Venture Fund, Osage University Partners, Takeda Ventures and The Column Group.
– Ribon will use the proceeds to support the clinical development of its novel precision medicine candidates.

Biotechnology Health Care Medical Device North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: